# Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

> **NCT05399732** · PHASE2 · COMPLETED · sponsor: **Bing Han** · enrollment: 58 (actual)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Luspatercept
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT05399732
- **Lead sponsor:** Bing Han
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-19
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-04-15
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05399732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05399732, "Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05399732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*